Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 05 11:44AM ET
20.16
Dollar change
+0.05
Percentage change
0.25
%
Index- P/E43.62 EPS (ttm)0.46 Insider Own81.85% Shs Outstand49.60M Perf Week0.80%
Market Cap5.50B Forward P/E34.71 EPS next Y0.58 Insider Trans0.00% Shs Float49.48M Perf Month-10.40%
Income124.25M PEG3.80 EPS next Q0.19 Inst Own20.11% Short Float7.40% Perf Quarter-5.66%
Sales1.19B P/S4.64 EPS this Y-17.23% Inst Trans3.36% Short Ratio7.07 Perf Half Y5.16%
Book/sh5.41 P/B3.73 EPS next Y15.10% ROA5.51% Short Interest3.66M Perf Year-20.03%
Cash/sh0.32 P/C63.14 EPS next 5Y11.47% ROE9.42% 52W Range16.56 - 34.73 Perf YTD-26.13%
Dividend Est.0.04 (0.18%) P/FCF- EPS past 5Y37.59% ROI6.91% 52W High-41.95% Beta0.59
Dividend TTM0.06 (0.29%) Quick Ratio1.21 Sales past 5Y18.75% Gross Margin26.69% 52W Low21.74% ATR (14)1.06
Dividend Ex-DateJun 04, 2024 Current Ratio1.81 EPS Y/Y TTM-22.61% Oper. Margin13.87% RSI (14)54.08 Volatility5.13% 6.49%
Employees- Debt/Eq0.27 Sales Y/Y TTM5.26% Profit Margin10.48% Recom1.55 Target Price25.57
Option/ShortYes / Yes LT Debt/Eq0.22 EPS Q/Q-22.30% Payout9.64% Rel Volume0.15 Prev Close20.11
Sales Surprise1.19% EPS Surprise-4.95% Sales Q/Q3.38% EarningsNov 05 BMO Avg Volume518.13K Price20.16
SMA200.69% SMA503.41% SMA200-9.73% Trades Volume28,588 Change0.25%
Date Action Analyst Rating Change Price Target Change
Dec-03-24Resumed Morgan Stanley Equal-Weight $23
Apr-22-24Initiated Exane BNP Paribas Outperform
Nov-01-23Downgrade Jefferies Buy → Hold $39 → $29
Sep-26-23Initiated Stephens Overweight $33
Sep-19-23Initiated CJS Securities Market Outperform
Aug-24-23Downgrade Morgan Stanley Overweight → Equal-Weight $34
Aug-10-21Initiated Wells Fargo Overweight $24
Aug-10-21Initiated Morgan Stanley Overweight $26
Aug-10-21Initiated KeyBanc Capital Markets Overweight $27
Aug-10-21Initiated Jefferies Buy $25
Dec-04-24 07:55AM
Nov-11-24 06:32AM
Nov-06-24 02:13AM
Nov-05-24 07:45AM
06:43AM
06:31AM Loading…
06:31AM
Nov-04-24 07:03AM
Oct-22-24 04:30PM
10:01AM
Oct-08-24 07:25AM
Oct-01-24 06:30AM
Sep-30-24 11:31AM
Sep-27-24 10:48AM
Sep-26-24 07:04AM
Sep-12-24 08:54AM
04:28AM Loading…
Sep-11-24 04:28AM
Aug-29-24 04:30PM
Aug-23-24 06:54AM
Aug-16-24 03:36AM
Aug-07-24 08:42AM
01:25AM
Aug-06-24 07:50AM
06:47AM
06:31AM
Jul-25-24 06:30AM
Jul-19-24 10:00AM
May-30-24 05:00AM
May-28-24 07:00AM
May-24-24 04:10PM
May-23-24 04:30PM
07:05AM Loading…
May-13-24 07:05AM
May-12-24 09:25AM
May-10-24 12:44AM
May-09-24 12:45PM
10:53AM
09:16AM
08:52AM
08:41AM
07:34AM
06:46AM
06:39AM
May-01-24 04:30PM
Apr-25-24 04:04PM
10:02AM
Apr-22-24 06:08PM
Apr-06-24 08:37PM
Apr-04-24 08:00AM
Apr-01-24 07:21AM
Mar-29-24 04:51AM
Mar-26-24 04:10PM
Mar-21-24 11:45PM
Mar-20-24 05:12PM
Mar-12-24 07:37AM
Mar-11-24 05:05PM
Mar-08-24 02:35PM
Mar-07-24 11:33PM
06:49AM
06:30AM
Mar-05-24 08:01AM
Feb-22-24 04:30PM
Feb-17-24 06:56AM
Jan-24-24 08:00AM
Jan-22-24 06:43AM
Jan-03-24 04:30PM
Dec-27-23 08:15AM
Dec-01-23 06:32AM
Nov-16-23 06:00AM
Nov-09-23 06:30AM
Nov-01-23 09:13AM
Oct-31-23 07:50AM
06:41AM
06:30AM
Oct-27-23 11:40AM
Oct-26-23 10:02AM
Oct-24-23 10:00AM
Oct-17-23 04:05PM
Oct-11-23 11:40AM
Oct-05-23 04:05PM
Sep-19-23 04:07PM
Sep-14-23 11:40AM
Sep-11-23 12:00PM
Aug-21-23 02:30AM
Jul-29-23 11:11AM
Jul-28-23 09:45AM
08:35AM
06:30AM
Jul-18-23 06:47AM
Jul-14-23 04:05PM
Jul-11-23 06:05PM
Jun-19-23 03:49AM
Jun-16-23 08:12AM
Jun-12-23 08:00AM
Jun-08-23 08:14AM
Jun-07-23 12:30PM
May-25-23 04:01AM
May-24-23 04:01PM
May-06-23 08:09AM
May-05-23 11:23AM
May-04-23 08:05AM
06:51AM
Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It operates through the following segments: Biopharmaceutical and Diagnostic Solutions, and Engineering segments. The Biopharmaceutical and Diagnostic Solutions segment includes all the products, processes, and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. The Engineering segment deals with all the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology and diagnostic manufacturing processes. The company was founded by Giovanni Stevanato in 1949 and is headquartered in Piombino Dese, Italy.